A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients
Figure 5.Prognostic value of the prognostic signature in the TCGA cohort. (A) the risk score and (B) the survival status of LUAD patients, (C) Kaplan-Meier survival analysis, (D) ROC analysis.